Results 241 to 250 of about 87,925 (315)

Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML [PDF]

, 2003
Shaun R. McCann, Kathy Gately, Eibhlin Conneally, Mark Lawler   +3 more
openalex   +1 more source

Re: Potential Use of Imatinib in Ewing's Sarcoma: Evidence for In Vitro and In Vivo Activity [PDF]

, 2003
Elena Tamborini, Luca Bonadiman, Veronica Albertini, Marco A. Pierotti, S. Pilotti   +4 more
openalex   +1 more source

Eyebrow whitening induced by imatinib

International Journal of Trichology, 2020
Atakan Turgutkaya, Irfan Yavasoglu, Zahit Bolaman   +2 more
openaire   +3 more sources

SOCS2 inhibits the tumorigenesis of GISTs and increases the sensitivity of GISTs to imatinib by suppression of KIT activation. [PDF]

Sci Rep
Zhang L, Xiao K, Zhang S, Zhao S, Liu Z, Wang M, Qin K, Yu Y, Li S, Ma L, Sun J.   +10 more
europepmc   +1 more source

Tyrosine Kinase Inhibitor Post-Allogeneic Stem Cell Transplantation in Adult Philadelphia-Positive B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions. [PDF]

Curr Issues Mol Biol
Canichella M, de Fabritiis P.
europepmc   +1 more source

Compatibility Studies of Different Crystal Forms of Imatinib Mesylate with Pharmaceutical Excipients. [PDF]

ACS Omega
Mou Y, Zhao Y, Wen S, Li X, Zhang W, Xu X, Wang Y.   +6 more
europepmc   +1 more source

FIP1L1::PDGFRA Fusion in a Pediatric Patient Presenting With B-Cell Lymphoblastic Leukemia. [PDF]

Genes Chromosomes Cancer
Nunn J, Williams B, Deambrosis D.
europepmc   +1 more source

Imatinib [PDF]

Reactions Weekly, 2020
openaire   +1 more source

Nail lichen planus associated with imatinib mesylate. [PDF]

JAAD Case Rep
Axler E, Loesch E, Vaidya T, Neubauer Z, Lipner SR.   +4 more
europepmc   +1 more source

Tyrosine kinase inhibitors modulate the expression of peroxiredoxins 1 and 2 in chronic myeloid leukemia cells. [PDF]

Leuk Res Rep
Kazama H, Wang YH, Tanaka J.
europepmc   +1 more source